Journal
CELL METABOLISM
Volume 27, Issue 5, Pages 988-+Publisher
CELL PRESS
DOI: 10.1016/j.cmet.2018.03.019
Keywords
-
Categories
Funding
- Monash MicroImaging Facility
- Australian National Health and Medical Research Council (NHMRC) [APP1081072, APP1101562]
- Australian Research Council Fellowships [DE140101164, FT170100313]
- Australian Research Council [FT170100313] Funding Source: Australian Research Council
Ask authors/readers for more resources
To fight infections, macrophages undergo a metabolic shift whereby increased glycolysis fuels antimicrobial inflammation and killing of pathogens. Here we demonstrate that the pathogen Candida albicans turns this metabolic reprogramming into an Achilles' heel for macrophages. During Candida-macrophage interactions intertwined metabolic shifts occur, with concomitant upregulation of glycolysis in both host and pathogen setting up glucose competition. Candida thrives on multiple carbon sources, but infected macrophages are metabolically trapped in glycolysis and depend on glucose for viability: Candida exploits this limitation by depleting glucose, triggering rapid macrophage death. Using pharmacological or genetic means to modulate glucose metabolism of host and/or pathogen, we show that Candida infection perturbs host glucose homeostasis in the murine candidemia model and demonstrate that glucose supplementation improves host outcomes. Our results support the importance of maintaining glucose homeostasis for immune cell survival during Candida challenge and for host survival in systemic infection.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available